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The development of echocardiographic methods and magnetic resonance for the evaluation of heart 
structure and function raises the question of the role of right-sided heart catheterization (RHC) or 
invasive hemodynamic evaluation (IHE) in valvular heart diseases. According to current guidelines, 
this method occupies a peripheral role and is reserved for situations where non-invasive testing is 
non-inclusive or discordant with clinical status1. As pulmonary hypertension (PH) is one of the criteria 
for surgery in asymptomatic aortic stenosis and mitral regurgitation (MR), it is especially important 
to measure it accurately. However, non-invasive measurement of PH based on echocardiography has 
its limitations and the possibility of error and is particularly problematic in the presence of severe 
tricuspid regurgitation (TR) and reduced right ventricular (RV) function. A typical example where this 
is particularly important is persistent severe TR after mitral valve surgery leading to dilatation and 
dysfunction of the RV. Cardiac reoperation carries an increased risk, but it is considered in the absence 
of left-sided valve dysfunction, severe RV or left ventricular (LV) dysfunction and severe pulmonary 
vascular resistance/hypertension where RHC plays a key role1. A particular problem for cardiac evalu-
ation is multiple and mixed valvular heart disease, especially in the presence of some other heart 
pathology such as coronary heart disease, LV dysfunction or constriction2. Exercise RHC is becoming 
increasingly popular in the diagnosis of heart failure with preserved systolic function, and now it is 
a question of its role in the diagnosis of valvular disease as well. The test has the potential to predict 
a worse outcome and thus for earlier surgery in asymptomatic patients e.g. with aortic stenosis or 
MR3. In conclusion, IHE is a useful and relatively harmless tool in the examination of valvular heart 
disease, but experience of cardiology teams is needed to get a true benefit of the method and to avoid 
misleading information. Gaining experience requires hard work perhaps even in cases where IHE is 
not fully indicated.
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